| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $127.6M | -14.8% |
| Cost of Revenue | $28.3M | +3.0% |
| R&D Expense | $42.1M | -3.4% |
| SG&A Expense | $73.8M | +67.1% |
| Operating Income | -$92.3M | -143.0% |
| Pre-tax Income | -$61.7M | -165.3% |
| Income Tax | -$3.0M | -232.0% |
| Net Income | -$58.6M | -129.4% |
| EPS (Basic) | -$1.59 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $79.4M | -56.9% |
| Accounts Receivable | $69.3M | +23.7% |
| Current Assets | $182.8M | -34.3% |
| Total Assets | $375.8M | -11.5% |
| Current Liabilities | $188.8M | -2.3% |
| Long-term Debt | $77.5M | — |
| Total Liabilities | $337.7M | -2.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$76.4M | -2145.0% |
| Capital Expenditures | $5.1M | +7.5% |
| Investing Cash Flow | -$54.9M | -353.4% |
| Financing Cash Flow | $26.3M | +142.5% |
| Free Cash Flow | -$81.5M | -7832.0% |
| -123.9% |
| EPS (Diluted) | -$1.59 | -123.9% |
| Stockholders' Equity |
| $38.1M |
| -52.2% |